Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7479d7b7d-pfhbr Total loading time: 0 Render date: 2024-07-11T01:31:34.602Z Has data issue: false hasContentIssue false

Chapter 20 - Vitrification of Human Oocytes as a Fertility Preservation Strategy

from Section 6 - Fertility Preservation Strategies in the Female: ART

Published online by Cambridge University Press:  27 March 2021

By
Ana Cobo ,
Aila Coello  and
Antonio Pellicer
Edited by
Jacques Donnez  and
S. Samuel Kim
Jacques Donnez
Affiliation:
Catholic University of Louvain, Brussels
S. Samuel Kim
Affiliation:
University of Kansas School of Medicine
Get access

Summary

Survival rates after cancer have increased significantly in recent decades; however, these treatments also have drawbacks, and patients (or parents in the case of children) must be informed of the long-term side effects of oncological treatments and the possible options for preserving the fertility of these patients. It is important to set out clearly the possible risks of developing ovarian failure or azoospermia with oncological treatments. These will depend on the age of the patients and on the type, dose and duration of chemotherapy, and on the field, dose and duration of radiotherapy.

Type
Chapter
Information
Fertility Preservation
Principles and Practice
 , pp. 215 - 224
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ataman, LM, Rodrigues, JK, Marinho, RM et al. Creating a global community of practice for oncofertility. J Glob Oncol, 2016;2:83–96.CrossRefGoogle ScholarPubMed
Meirow, D, Epstein, M, Lewis, H, Nugent, D, Gosden, RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod, 2001;16:632–637.CrossRefGoogle ScholarPubMed
Bernatsky, S, Clarke, AE, Suissa, S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med, 2008;168:378–381.CrossRefGoogle ScholarPubMed
Schroeder, JO, Euler, HH, Loffler, H. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med, 1987;107:344–346.Google Scholar
Langford, CA. Update on Wegener granulomatosis. Cleve Clin J Med, 2005;72:689–690, 693–697.Google Scholar
Rauck, AM, Grovas, AC. Bone marrow transplantation in adolescents. Adolesc Med, 1999;10:445–449, xi–xii.Google Scholar
Berlanda, N, Vercellini, P, Fedele, L. The outcomes of repeat surgery for recurrent symptomatic endometriosis. Curr Opin Obstet Gynecol, 2010;22:320–325.CrossRefGoogle ScholarPubMed
Garcia-Velasco, JA, Somigliana, E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod, 2009;24:496–501.Google Scholar
Stoop, D, Cobo, A, Silber, S. Fertility preservation for age-related fertility decline. Lancet, 2014;384:1311–1319.Google Scholar
Cobo, A, Garcia-Velasco, JA. Why all women should freeze their eggs. Curr Opin Obstet Gynecol, 2016;28:206–210.Google Scholar
Garcia-Velasco, JA, Domingo, J, Cobo, A et al. Five years’ experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril, 2013;99:1994–1999.Google Scholar
Imbert, R, Moffa, F, Tsepelidis, S et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. Hum Reprod, 2014;29:1931–1940.CrossRefGoogle ScholarPubMed
Donnez, J, Dolmans, MM. Fertility preservation in women. N Engl J Med, 2017;377:1657–1665.CrossRefGoogle ScholarPubMed
Kim, SY, Kim, SK, Lee, JR, Woodruff, TK. Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women. J Gynecol Oncol, 2016;27:e22.Google Scholar
Diaz-Garcia, C, Domingo, J, Garcia-Velasco, J et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril, 2018;109(3):478–485.Google Scholar
Dolmans, MM, Manavella, DD. Recent advances in fertility preservation. J Obstet Gynaecol Res, 2019;45:266–279.Google Scholar
Mahajan, N. Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci, 2015;8:3–13.Google Scholar
Chen, C. Pregnancy after human oocyte cryopreservation. Lancet, 1986;1:884–886.Google Scholar
Fahy, GM, Wowk, B, Wu, J, Paynter, S. Improved vitrification solutions based on the predictability of vitrification solution toxicity. Cryobiology, 2004;48:22–35.Google Scholar
Rall, WF, Fahy, GM. Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification. Nature, 1985;313:573–575.Google Scholar
Coello, A, Campos, P, Remohi, J, Meseguer, M, Cobo, A. A combination of hydroxypropyl cellulose and trehalose as supplementation for vitrification of human oocytes: a retrospective cohort study. J Assist Reprod Genet, 2016;33:413–421.CrossRefGoogle ScholarPubMed
Cobo, A, Kuwayama, M, Perez, S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril, 2008;89:1657–1664.CrossRefGoogle ScholarPubMed
Seki, S, Mazur, P. The dominance of warming rate over cooling rate in the survival of mouse oocytes subjected to a vitrification procedure. Cryobiology, 2009;59:75–82.CrossRefGoogle ScholarPubMed
Cobo, A, Serra, V, Garrido, N et al. Obstetric and perinatal outcome of babies born from vitrified oocytes.Fertil Steril, 2014;102:1006–1015.e4.Google Scholar
Meirow, D, Nugent, D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update, 2001;7:535–543.Google Scholar
Poniatowski, BC, Grimm, P, Cohen, G. Chemotherapy-induced menopause: a literature review. Cancer Invest, 2001;19:641–648.CrossRefGoogle ScholarPubMed
Sonmezer, M, Oktay, K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist, 2006;11:422–434.Google Scholar
Qin, N, Chen, Q, Hong, Q et al. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril, 2016;106:334–341.e1.Google Scholar
Ubaldi, FM, Capalbo, A, Vaiarelli, A et al. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril, 2016;105:1488–1495.e1.CrossRefGoogle Scholar
Cakmak, H, Rosen, MP. Random-start ovarian stimulation in patients with cancer. Curr Opin Obstet Gynecol, 2015;27:215–221.Google Scholar
Kim, JH, Kim, SK, Lee, HJ et al. Efficacy of random-start controlled ovarian stimulation in cancer patients. J Korean Med Sci, 2015;30:290–295.Google Scholar
Cobo, A, Garcia-Velasco, J, Domingo, J, Pellicer, A, Remohi, J. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum Reprod, 2018;33:2222–2231.CrossRefGoogle ScholarPubMed
Platet, N, Cathiard, AM, Gleizes, M, Garcia, M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol, 2004;51:55–67.Google Scholar
Butt, AJ, Caldon, CE, McNeil, CM et al. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv Exp Med Biol, 2008;630:189–205.CrossRefGoogle ScholarPubMed
Oktay, K, Turan, V, Bedoschi, G, Pacheco, FS, Moy, F. Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer. J Clin Oncol, 2015;33:2424–2429.CrossRefGoogle ScholarPubMed
Domingo, J, Garcia-Velasco, JA. Oocyte cryopreservation for fertility preservation in women with cancer. Curr Opin Endocrinol Diabetes Obes, 2016;23:465–469.Google Scholar
Sanchez-Serrano, M, Crespo, J, Mirabet, V et al. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril, 2010;93:268.e11–268.e13.CrossRefGoogle ScholarPubMed
Kim, MK, Lee, DR, Han, JE et al. Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation. J Assist Reprod Genet, 2011;28:1167–1170.Google Scholar
Alvarez, M, Sole, M, Devesa, M et al. Live birth using vitrified–warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online, 2014;28:663–668.Google Scholar
da Motta, EL, Bonavita, M, Alegretti, JR, Chehin, M, Serafini, P. Live birth after 6 years of oocyte vitrification in a survivor with breast cancer. J Assist Reprod Genet, 2014;31:1397–1400.Google Scholar
Cobo, A, Garcia-Velasco, JA, Coello, A et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril, 2016;105:755–64.e8.CrossRefGoogle ScholarPubMed
Doyle, JO, Richter, KS, Lim, J et al. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril, 2016;105:459–466.e2.Google Scholar
Cardozo, ER, Thomson, AP, Karmon, AE et al. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience. J Assist Reprod Genet, 2015;32:587–596.Google Scholar
Quinn, MM, Cakmak, H, Letourneau, JM, Cedars, MI, Rosen, MP. Response to ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod, 2017;32:568–574.Google Scholar
Dolinko, AV, Farland, LV, Missmer, SA et al. Responses to fertility treatment among patients with cancer: a retrospective cohort study.Fertil Res Pract, 2018;4:3–018-0048–2. eCollection 2018.CrossRefGoogle ScholarPubMed
Tsampras, N, Roberts, SA, Gould, D, Fitzgerald, CT. Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients. Eur J Cancer Care (Engl), 2018;27:e12797.CrossRefGoogle ScholarPubMed
Friedler, S, Koc, O, Gidoni, Y, Raziel, A, Ron-El, R. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril, 2012;97:125–133.Google Scholar
Oktay, K, Hourvitz, A, Sahin, G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab, 2006;91:3885–3890.Google Scholar
Domingo, J, Guillen, V, Ayllon, Y et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril, 2012;97:930–934.CrossRefGoogle ScholarPubMed
Deighton, KJ. Cancer–a systemic disease with local manifestations. Med Hypotheses, 1975;1:37–41.Google Scholar
Jatoi, I. Breast cancer: a systemic or local disease? Am J Clin Oncol, 1997;20:536–539.Google Scholar
Leone, BA, Leone, J, Leone, JP. Breast cancer is a systemic disease rather than an anatomical process. Breast Cancer Res Treat, 2017;161:619–017-4104–0. Epub 2017 January 9.Google Scholar
Goldman, RH, Racowsky, C, Farland, LV et al. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod, 2017;32:853–859.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×